Methyl N-[(1R)-2-[[7-[6-[2-[[[2-(methoxycarbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]naphthalen-2-yl]-3H-benzo[e]benzimidazol-2-yl]methyl-propylamino]-2-oxo-1-phenylethyl]carbamate
C46H48N8O6 — CID 146518679
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[(1R)-2-[[7-[6-[2-[[[2-(methoxycarbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]naphthalen-2-yl]-3H-benzo[e]benzimidazol-2-yl]methyl-propylamino]-2-oxo-1-phenylethyl]carbamate
Methyl N-[(1R)-2-[[7-[6-[2-[[[2-(methoxycarbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]naphthalen-2-yl]-3H-benzo[e]benzimidazol-2-yl]methyl-propylamino]-2-oxo-1-phenylethyl]carbamate (PubChem CID 146518679) has the molecular formula C46H48N8O6 and a molecular weight of 808.94 g/mol. Its IUPAC name is methyl N-[(1R)-2-[[7-[6-[2-[[[2-(methoxycarbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]naphthalen-2-yl]-3H-benzo[e]benzimidazol-2-yl]methyl-propylamino]-2-oxo-1-phenylethyl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[(1R)-2-[[7-[6-[2-[[[2-(methoxycarbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]naphthalen-2-yl]-3H-benzo[e]benzimidazol-2-yl]methyl-propylamino]-2-oxo-1-phenylethyl]carbamate |
|---|---|
| PubChem CID | 146518679 |
| Molecular Formula | C46H48N8O6 |
| Molecular Weight | 808.94 g/mol |
| Exact Mass | 808.37 |
| IUPAC Name | methyl N-[(1R)-2-[[7-[6-[2-[[[2-(methoxycarbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]naphthalen-2-yl]-3H-benzo[e]benzimidazol-2-yl]methyl-propylamino]-2-oxo-1-phenylethyl]carbamate |
| SMILES | CCCN(Cc1ncc(-c2ccc3cc(-c4ccc5c(ccc6[nH]c(CN(CCC)C(=O)[C@H](NC(=O)OC)c7ccccc7)nc65)c4)ccc3c2)[nH]1)C(=O)CNC(=O)OC |
| InChI | InChI=1S/C46H48N8O6/c1-5-20-53(41(55)26-48-45(57)59-3)27-39-47-25-38(50-39)35-15-14-31-22-30(12-13-32(31)24-35)33-16-18-36-34(23-33)17-19-37-43(36)51-40(49-37)28-54(21-6-2)44(56)42(52-46(58)60-4)29-10-8-7-9-11-29/h7-19,22-25,42H,5-6,20-21,26-28H2,1-4H3,(H,47,50)(H,48,57)(H,49,51)(H,52,58)/t42-/m1/s1 |
| InChIKey | BRYWARDAZQSOIW-HUESYALOSA-N |
| XLogP | 7.86 |
| TPSA | 174.64 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 60 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 808.94 |
| LogP ≤ 5 | 7.86 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146518679 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.